Bone mineral density in patients with hepatic glycogen storage diseases

Detalhes bibliográficos
Autor(a) principal: Jacoby, Jesica Tamara
Data de Publicação: 2021
Outros Autores: Santos, Bruna Bento dos, Nalin, Tatiéle, Colonetti, Karina, Refosco, Lilia Farret, Souza, Carolina Fischinger Moura de, Spritzer, Poli Mara, Poloni, Soraia, Mendes, Roberta Hack, Schwartz, Ida Vanessa Doederlein
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/232609
Resumo: The association between bone mineral density (BMD) and hepatic glycogen storage diseases (GSDs) is still unclear. To evaluate the BMD of patients with GSD I, IIIa and IXα, a cross-sectional study was performed, including 23 patients (GSD Ia = 13, Ib = 5, IIIa = 2 and IXα = 3; median age = 11.9 years; IQ = 10.9–20.1) who underwent a dual-energy X-ray absorptiometry (DXA). Osteocalcin (OC, n = 18), procollagen type 1 N-terminal propeptide (P1NP, n = 19), collagen type 1 C-terminal telopeptide (CTX, n = 18) and 25-OH Vitamin D (n = 23) were also measured. The participants completed a 3-day food diary (n = 20). Low BMD was defined as a Z-score ≤ −2.0. All participants were receiving uncooked cornstarch (median dosage = 6.3 g/kg/day) at inclusion, and 11 (47.8%) presented good metabolic control. Three (13%) patients (GSD Ia = 1, with poor metabolic control; IIIa = 2, both with high CPK levels) had a BMD ≤ −2.0. CTX, OC and P1NP correlated negatively with body weight and age. 25-OH Vitamin D concentration was decreased in seven (30.4%) patients. Our data suggest that patients with hepatic GSDs may have low BMD, especially in the presence of muscular involvement and poor metabolic control. Systematic nutritional monitoring of these patients is essential.
id UFRGS-2_f9eed0fe6825fff05ef81361afb76d2f
oai_identifier_str oai:www.lume.ufrgs.br:10183/232609
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Jacoby, Jesica TamaraSantos, Bruna Bento dosNalin, TatiéleColonetti, KarinaRefosco, Lilia FarretSouza, Carolina Fischinger Moura deSpritzer, Poli MaraPoloni, SoraiaMendes, Roberta HackSchwartz, Ida Vanessa Doederlein2021-12-07T04:31:02Z20212072-6643http://hdl.handle.net/10183/232609001134120The association between bone mineral density (BMD) and hepatic glycogen storage diseases (GSDs) is still unclear. To evaluate the BMD of patients with GSD I, IIIa and IXα, a cross-sectional study was performed, including 23 patients (GSD Ia = 13, Ib = 5, IIIa = 2 and IXα = 3; median age = 11.9 years; IQ = 10.9–20.1) who underwent a dual-energy X-ray absorptiometry (DXA). Osteocalcin (OC, n = 18), procollagen type 1 N-terminal propeptide (P1NP, n = 19), collagen type 1 C-terminal telopeptide (CTX, n = 18) and 25-OH Vitamin D (n = 23) were also measured. The participants completed a 3-day food diary (n = 20). Low BMD was defined as a Z-score ≤ −2.0. All participants were receiving uncooked cornstarch (median dosage = 6.3 g/kg/day) at inclusion, and 11 (47.8%) presented good metabolic control. Three (13%) patients (GSD Ia = 1, with poor metabolic control; IIIa = 2, both with high CPK levels) had a BMD ≤ −2.0. CTX, OC and P1NP correlated negatively with body weight and age. 25-OH Vitamin D concentration was decreased in seven (30.4%) patients. Our data suggest that patients with hepatic GSDs may have low BMD, especially in the presence of muscular involvement and poor metabolic control. Systematic nutritional monitoring of these patients is essential.application/pdfengNutrients. Basel. Vol. 13, no. 9 (Sept. 2021), 2987, 11 p.Densidade ósseaDoença de depósito de glicogênioOsteocalcinaGlycogen storage diseaseBone mineral densityGSDBoneOsteocalcinPhoton absorptiometryBone mineral density in patients with hepatic glycogen storage diseasesEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001134120.pdf.txt001134120.pdf.txtExtracted Texttext/plain45421http://www.lume.ufrgs.br/bitstream/10183/232609/2/001134120.pdf.txt8e66b50a82eea290aa33a3b7ddbeb464MD52ORIGINAL001134120.pdfTexto completo (inglês)application/pdf716642http://www.lume.ufrgs.br/bitstream/10183/232609/1/001134120.pdf2fde56dd495550fbb1bcb7f2b43677b6MD5110183/2326092021-12-09 05:34:17.62353oai:www.lume.ufrgs.br:10183/232609Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2021-12-09T07:34:17Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Bone mineral density in patients with hepatic glycogen storage diseases
title Bone mineral density in patients with hepatic glycogen storage diseases
spellingShingle Bone mineral density in patients with hepatic glycogen storage diseases
Jacoby, Jesica Tamara
Densidade óssea
Doença de depósito de glicogênio
Osteocalcina
Glycogen storage disease
Bone mineral density
GSD
Bone
Osteocalcin
Photon absorptiometry
title_short Bone mineral density in patients with hepatic glycogen storage diseases
title_full Bone mineral density in patients with hepatic glycogen storage diseases
title_fullStr Bone mineral density in patients with hepatic glycogen storage diseases
title_full_unstemmed Bone mineral density in patients with hepatic glycogen storage diseases
title_sort Bone mineral density in patients with hepatic glycogen storage diseases
author Jacoby, Jesica Tamara
author_facet Jacoby, Jesica Tamara
Santos, Bruna Bento dos
Nalin, Tatiéle
Colonetti, Karina
Refosco, Lilia Farret
Souza, Carolina Fischinger Moura de
Spritzer, Poli Mara
Poloni, Soraia
Mendes, Roberta Hack
Schwartz, Ida Vanessa Doederlein
author_role author
author2 Santos, Bruna Bento dos
Nalin, Tatiéle
Colonetti, Karina
Refosco, Lilia Farret
Souza, Carolina Fischinger Moura de
Spritzer, Poli Mara
Poloni, Soraia
Mendes, Roberta Hack
Schwartz, Ida Vanessa Doederlein
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Jacoby, Jesica Tamara
Santos, Bruna Bento dos
Nalin, Tatiéle
Colonetti, Karina
Refosco, Lilia Farret
Souza, Carolina Fischinger Moura de
Spritzer, Poli Mara
Poloni, Soraia
Mendes, Roberta Hack
Schwartz, Ida Vanessa Doederlein
dc.subject.por.fl_str_mv Densidade óssea
Doença de depósito de glicogênio
Osteocalcina
topic Densidade óssea
Doença de depósito de glicogênio
Osteocalcina
Glycogen storage disease
Bone mineral density
GSD
Bone
Osteocalcin
Photon absorptiometry
dc.subject.eng.fl_str_mv Glycogen storage disease
Bone mineral density
GSD
Bone
Osteocalcin
Photon absorptiometry
description The association between bone mineral density (BMD) and hepatic glycogen storage diseases (GSDs) is still unclear. To evaluate the BMD of patients with GSD I, IIIa and IXα, a cross-sectional study was performed, including 23 patients (GSD Ia = 13, Ib = 5, IIIa = 2 and IXα = 3; median age = 11.9 years; IQ = 10.9–20.1) who underwent a dual-energy X-ray absorptiometry (DXA). Osteocalcin (OC, n = 18), procollagen type 1 N-terminal propeptide (P1NP, n = 19), collagen type 1 C-terminal telopeptide (CTX, n = 18) and 25-OH Vitamin D (n = 23) were also measured. The participants completed a 3-day food diary (n = 20). Low BMD was defined as a Z-score ≤ −2.0. All participants were receiving uncooked cornstarch (median dosage = 6.3 g/kg/day) at inclusion, and 11 (47.8%) presented good metabolic control. Three (13%) patients (GSD Ia = 1, with poor metabolic control; IIIa = 2, both with high CPK levels) had a BMD ≤ −2.0. CTX, OC and P1NP correlated negatively with body weight and age. 25-OH Vitamin D concentration was decreased in seven (30.4%) patients. Our data suggest that patients with hepatic GSDs may have low BMD, especially in the presence of muscular involvement and poor metabolic control. Systematic nutritional monitoring of these patients is essential.
publishDate 2021
dc.date.accessioned.fl_str_mv 2021-12-07T04:31:02Z
dc.date.issued.fl_str_mv 2021
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/232609
dc.identifier.issn.pt_BR.fl_str_mv 2072-6643
dc.identifier.nrb.pt_BR.fl_str_mv 001134120
identifier_str_mv 2072-6643
001134120
url http://hdl.handle.net/10183/232609
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Nutrients. Basel. Vol. 13, no. 9 (Sept. 2021), 2987, 11 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/232609/2/001134120.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/232609/1/001134120.pdf
bitstream.checksum.fl_str_mv 8e66b50a82eea290aa33a3b7ddbeb464
2fde56dd495550fbb1bcb7f2b43677b6
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801225044940029952